Evidence map›Paper›PMID 42697809›Full record

ArticleWomen's health issues : official publication of the Jacobs Institute of Women's Health2026

Postpartum Hospital Readmissions Among Women With Gestational Diabetes and Pregestational Diabetes in the United States, 2016 to 2022.

Barbara H Bardenheier, Jean M Lawrence, Ibrahim Zaganjor, Oscar Rincón-Guevara, Osatohamwen I Idubor, Catherine E Barrett, Dayna S Alexander, Christopher Holliday, Holly Du, Kai McKeever Bullard

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Women's health issues : official publication of the Jacobs Institute of Women's Health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Barbara H BardenheierDivision of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: bfb7@cdc.gov.
Jean M LawrenceDivision of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland; Diabetes, Endocrinology, & Obesity Branch, Division of Intramural Research, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Ibrahim ZaganjorDivision of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Oscar Rincón-GuevaraPlatforms Division, Office of the Director, Centers for Disease Control and Prevention, Atlanta, Georgia.
Osatohamwen I IduborDivision of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Catherine E BarrettOffice of the Director, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Dayna S AlexanderDivision of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Christopher HollidayDivision of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Holly DuDivision of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Kai McKeever BullardDivision of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectiveWe estimated postpartum hospital readmissions trends among women with gestational diabetes mellitus (GDM), pregestational diabetes mellitus (PDM; i.e., diabetes present before pregnancy), and neither.

methodsUsing the National Readmissions Database, we identified women aged 15-44 years who had a live birth or stillbirth between January 1 and June 30 annually, from 2016 through 2022. Births by diabetes status (GDM, PDM, and no diabetes diagnosis) were grouped to obtain the 1) rates of postpartum rehospitalization for all causes, severe maternal morbidity (SMM), diabetes-related diagnoses, and mental health-related diagnoses, 2) repeated admissions, and 3) the leading causes of readmission. Joinpoint regression was used to assess trends in outcomes for 30, 60, and 180 days postpartum.

resultsFrom 2016 to 2022, rates of all-cause postpartum readmissions increased significantly among women with GDM and women without diabetes by 30 days (annual percent change [APC], 2.78 for both), whereas rates of SMM postpartum readmissions decreased significantly among women with GDM by 30 days (APC, -7.44), 60 days (APC, -7.12), and 180 days (APC, -6.37), among women with PDM by 60 days (APC, -7.05), and among women with no diabetes by 30 days (APC, -5.83), 60 days (APC, -5.68), and 180 days (APC, -4.45). Postpartum diabetes-related readmission rates decreased for all periods among women with GDM and without diabetes (APC p values < .05) and by 180 days among women with PDM (APC, -7.03). Repeated diabetes-related admissions decreased at 60 and 180 days postpartum (APC p values < .05) among women with PDM. Hypertensive disorders were among the top three reasons for readmissions, regardless of diabetes status.

conclusionAlthough all-cause readmissions increased by 30 days among women with GDM and without diabetes, postpartum SMM and diabetes-related readmissions decreased overall among women with GDM, PDM, and neither. Hypertensive disorders as a top reason for readmission suggests the need to monitor these disorders among women with GDM and PDM at birth.

Identifiers

PMID42697809
PMCPMC13628306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.